Regulation, Transparency Are Key in the Conflict Between PBMs and Pharma
Currently, 6 separate bills have come out of congressional committees to increase pharmacy benefit managers regulation, with more transparency being the common factor.
Benefits and Efficiencies Abound, but AI Misses the Humanity of Care
Response to Oncologic Drug Shortages Falls on Key Payers
Although drug shortages are not new, the number of drugs involved is increasing and resolutions seem to take longer, and oncology care is often affected by these shortages.
